Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 1/20 | 0.42 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.42 |
| ▸ | TYMP | P19971 | 1/20 | 0.42 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31685622 | 0.82 | MAPT (0.51) | TYMP | |
| SCHEMBL7764746 | 0.82 | MAPT (0.51) | TYMP | |
| SCHEMBL16781797 | 0.82 | MAPT (0.51) | TYMP | |
| SCHEMBL31685467 | 0.82 | P2RY2 (0.57) | P2RY2DNPH1 | |
| SCHEMBL31685623 | 0.81 | CYP2C19 (0.47) | P2RY2ADORA1CYP2C19HIF1A | |
| SCHEMBL1904388 | 0.80 | TYMP (0.59) | TYMPDNPH1 | |
| SCHEMBL31685600 | 0.80 | TK2 (0.44) | TYMP | |
| SCHEMBL31685284 | 0.80 | UMPS (0.53) | P2RY2ADORA1CYP2C19HIF1A | |
| SCHEMBL31685559 | 0.79 | ADORA1 (0.52) | P2RY2ADORA1DNPH1 | |
| SCHEMBL8847369 | 0.79 | ADORA1 (0.49) | ADORA1CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | P2RY2 3116/4885ADORA1 935/4885TYMP 1847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.